Model using routine clinical data may predict pancreatic cancer risk
New study reveals potential target for alcohol-associated liver disease
14 February 2022MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer
14 February 2022Model using routine clinical data may predict pancreatic cancer risk
(HealthDay)—A model using routine clinical information can predict pancreatic ductal adenocarcinoma (PDA) following diagnosis of impaired fasting glucose (IFG), according to a study published in the January issue of the European Journal of Gastroenterology & Hepatology.
